#BioLIVE2026 | Big Pharma

The European market for biologics formulation and delivery is experiencing rapid growth as next-generation therapeutics, including RNA-based medicines, vaccines, and complex biologics, become essential in addressing global health challenges. As drug development advances, optimising formulation strategies, delivery mechanisms, and stability is critical to ensuring efficacy, manufacturability, and patient accessibility. BioFormulate Live 2026 is a must-attend event for industry professionals tackling these key challenges, from enhancing drug stability and bioavailability to meeting evolving regulatory requirements.

BioFormulate Live 2026 will provide a comprehensive platform for experts and industry leaders to explore the latest innovations in biologics formulation. With dedicated streams covering RNA Therapeutics & Development, Vaccine Innovations, and Biologics Formulation & Delivery, the event will delve into cutting-edge formulation techniques, novel excipients, and advanced drug delivery technologies. Sessions will also highlight key advancements in lyophilization, high-concentration biologics, and automation in formulation development, offering actionable insights to optimize drug product performance.

Beyond technical discussions, BioFormulate Live 2026 fosters an intimate networking environment, enabling one-on-one meetings and strategic collaborations among industry pioneers. More than just a conference, it serves as a crucial forum for shaping the future of biologics formulation and delivery in Europe. By addressing both current industry hurdles and future opportunities, BioFormulate Live 2026 is essential for professionals looking to drive innovation in biopharmaceutical development.